Protocols
1 protocol(s) meet the specified criteria
Drug: NAVELBINE
Protocol No.TitleStatus
IMMU-132-05An International, Multi-Center, Open-Label, Randomized, Phase III Trial of Sacituzumab Govitecan versus Treatment of Physician Choice in Patients with Metastatic Triple-Negative Breast Cancer Who Received at Least Two Prior TreatmentsOpen